Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
- PMID: 15084273
- DOI: 10.1016/s1074-7613(04)00079-2
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
Abstract
Peripheral autoantigen binding B cells are poorly competitive with naive B cells for survival and undergo rapid cell death. However, in monoclonal Ig-transgenic mice lacking competitor B cells, autoantigen binding B cells can survive for extended periods. The basis for competitive elimination of autoantigen binding B cells has been unknown. Here we demonstrate that autoantigen binding B cells have increased dependence on BAFF for survival. In monoclonal Ig-transgenic mice, each autoantigen binding B cell receives elevated amounts of BAFF, exhibiting increased levels of NFkappaB p52 and of the prosurvival kinase Pim2. When placed in a diverse B cell compartment, BAFF receptor engagement and signaling are reduced and the autoantigen binding cells are unable to protect themselves from Bim and possibly other death-promoting factors induced by chronic BCR signaling. These findings indicate that under conditions where BAFF levels are elevated, autoantigen-engaged cells will be rescued from rapid competitive elimination, predisposing to the development of autoimmune disease.
Comment in
-
Tipping the scales of selection with BAFF.Immunity. 2004 Jun;20(6):655-6. doi: 10.1016/j.immuni.2004.06.001. Immunity. 2004. PMID: 15189730
Similar articles
-
Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.Eur J Immunol. 2006 Sep;36(9):2504-14. doi: 10.1002/eji.200636270. Eur J Immunol. 2006. PMID: 16906535
-
Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B-1 cell survival in transgenic mice expressing a low level of Igkappa-reactive macroself antigen.Eur J Immunol. 2006 Apr;36(4):985-96. doi: 10.1002/eji.200535581. Eur J Immunol. 2006. PMID: 16511898
-
The BAFF/APRIL system: an important player in systemic rheumatic diseases.Curr Dir Autoimmun. 2005;8:243-65. doi: 10.1159/000082106. Curr Dir Autoimmun. 2005. PMID: 15564724 Review.
-
Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.Immunity. 2004 Oct;21(4):575-87. doi: 10.1016/j.immuni.2004.09.001. Immunity. 2004. PMID: 15485634
-
BAFF AND APRIL: a tutorial on B cell survival.Annu Rev Immunol. 2003;21:231-64. doi: 10.1146/annurev.immunol.21.120601.141152. Epub 2001 Dec 19. Annu Rev Immunol. 2003. PMID: 12427767 Review.
Cited by
-
Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development.F1000Res. 2024 Jan 10;13:54. doi: 10.12688/f1000research.143472.1. eCollection 2024. F1000Res. 2024. PMID: 38681509 Free PMC article. Review.
-
B cell focused transient immune suppression protocol for efficient AAV readministration to the liver.Mol Ther Methods Clin Dev. 2024 Feb 20;32(1):101216. doi: 10.1016/j.omtm.2024.101216. eCollection 2024 Mar 14. Mol Ther Methods Clin Dev. 2024. PMID: 38440160 Free PMC article.
-
Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity.J Exp Med. 2024 Apr 1;221(4):e20221080. doi: 10.1084/jem.20221080. Epub 2024 Feb 28. J Exp Med. 2024. PMID: 38417019 Free PMC article.
-
Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sensory sensitivity.Front Immunol. 2024 Feb 1;15:1288187. doi: 10.3389/fimmu.2024.1288187. eCollection 2024. Front Immunol. 2024. PMID: 38361924 Free PMC article.
-
Clinical research progress of novel biologics for the treatment of lupus nephritis.Clin Exp Med. 2023 Dec;23(8):4153-4162. doi: 10.1007/s10238-023-01143-9. Epub 2023 Jul 22. Clin Exp Med. 2023. PMID: 37481481 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources